Zeidan AM, DeAngelo DJ, Palmer J, Seet CS, et al. Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes. Ann Hematol 2022 Jan 4. pii: 10.1007/s00277-021-04734.
PMID: 34981142